IRIS Accounts Production v25.1.0.734 09177095 Board of Directors 1.1.24 31.12.24 31.12.24 0 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh091770952023-12-31091770952024-12-31091770952024-01-012024-12-31091770952022-12-31091770952023-01-012023-12-31091770952023-12-3109177095ns15:EnglandWales2024-01-012024-12-3109177095ns14:PoundSterling2024-01-012024-12-3109177095ns10:Director12024-01-012024-12-3109177095ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3109177095ns10:SmallEntities2024-01-012024-12-3109177095ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3109177095ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3109177095ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3109177095ns10:FullAccounts2024-01-012024-12-3109177095ns10:OrdinaryShareClass12024-01-012024-12-3109177095ns10:Director22024-01-012024-12-3109177095ns10:RegisteredOffice2024-01-012024-12-3109177095ns5:CurrentFinancialInstruments2024-12-3109177095ns5:CurrentFinancialInstruments2023-12-3109177095ns5:ShareCapital2024-12-3109177095ns5:ShareCapital2023-12-3109177095ns5:RetainedEarningsAccumulatedLosses2024-12-3109177095ns5:RetainedEarningsAccumulatedLosses2023-12-3109177095ns5:PlantMachinery2024-01-012024-12-3109177095ns5:PlantMachinery2024-12-3109177095ns10:OrdinaryShareClass12024-12-31
REGISTERED NUMBER: 09177095 (England and Wales)











UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

PHARMA DELIVERY DEVICE CONSULTING LTD

PHARMA DELIVERY DEVICE CONSULTING LTD (REGISTERED NUMBER: 09177095)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


PHARMA DELIVERY DEVICE CONSULTING LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTORS: A J Hannan
Y Hannan





REGISTERED OFFICE: 10 Jesus Lane
Cambridge
England
CB5 8BA





REGISTERED NUMBER: 09177095 (England and Wales)





ACCOUNTANTS: Thompson Taraz Rand Ltd
Chartered Accountants
10 Jesus Lane
Cambridge
Cambridgeshire
CB5 8BA

PHARMA DELIVERY DEVICE CONSULTING LTD (REGISTERED NUMBER: 09177095)

BALANCE SHEET
31 DECEMBER 2024

2024 2023
Notes £    £   
FIXED ASSETS
Tangible assets 5 1,875 -

CURRENT ASSETS
Cash at bank 51,527 45,794

CREDITORS
Amounts falling due within one year 6 (22,191 ) (20,797 )
NET CURRENT ASSETS 29,336 24,997
TOTAL ASSETS LESS CURRENT LIABILITIES 31,211 24,997

CAPITAL AND RESERVES
Called up share capital 7 2 2
Retained earnings 31,209 24,995
SHAREHOLDERS' FUNDS 31,211 24,997

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 May 2025 and were signed on its behalf by:





A J Hannan - Director


PHARMA DELIVERY DEVICE CONSULTING LTD (REGISTERED NUMBER: 09177095)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1. STATUTORY INFORMATION

Pharma Delivery Device Consulting Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover represents net invoiced sales in relation to management consultancy services, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost and 10% on cost

Financial instruments
Basic financial assets and basic financial liabilities as defined under section 11 of FRS 102, including trade and other debtors, trade and other creditors, cash and bank balances and investments in commercial paper, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. hose held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss using the effective interest method over the relevant period. The capital element of the future payments is treated as a liability.

Grants
Grant funding has been recognised using the accrual method. Were the grant relates to the acquisition of a capital asset the grant will be released to the profit and loss account over the term of the corresponding hire purchase agreement that correlates to the asset.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

PHARMA DELIVERY DEVICE CONSULTING LTD (REGISTERED NUMBER: 09177095)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
Additions 2,500
At 31 December 2024 2,500
DEPRECIATION
Charge for year 625
At 31 December 2024 625
NET BOOK VALUE
At 31 December 2024 1,875

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 6,209 6,481
Other creditors 15,982 14,316
22,191 20,797

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
2 Ordinary £1 2 2